Emerald Advisers, LLC
- SEC CIK
- 0001015083
- Latest filing
- Aug 5, 2026
SRPT holding history
Sarepta Therapeutics, Inc. in every 13F filed by Emerald Advisers, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SRPT overviewAll 13F holders of SRPTFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −19,830−100.0% | Sold out | Holders |
| Q1 2025 | 19,830 | $1.27M | 0.1% | +6,588+49.8% | Added | Holders |
| Q4 2024 | 13,242 | $1.61M | 0.1% | +4,904+58.8% | Added | Holders |
| Q3 2024 | 8,338 | $1.04M | <0.1% | +4,059+94.9% | Added | Holders |
| Q2 2024 | 4,279 | $676.1K | <0.1% | +2,426+130.9% | Added | Holders |
| Q1 2024 | 1,853 | $239.9K | <0.1% | +1,853 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −3,454−100.0% | Sold out | Holders |
| Q3 2023 | 3,454 | $418.7K | <0.1% | −72−2.0% | Reduced | Holders |
| Q2 2023 | 3,526 | $403.8K | <0.1% | −8,814−71.4% | Reduced | Holders |
| Q1 2023 | 12,340 | $1.70M | 0.1% | −3,448−21.8% | Reduced | Holders |
| Q4 2022 | 15,788 | $2.05M | 0.1% | −325−2.0% | Reduced | Holders |
| Q3 2022 | 16,113 | $1.78M | 0.1% | +12,369+330.4% | Added | Holders |
| Q2 2022 | 3,744 | $281.0K | <0.1% | +3,744 | New | Holders |